Patents by Inventor Zongcen Charles Xie

Zongcen Charles Xie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7150995
    Abstract: The invention provides a system for quantitative measurement of percent glycated hemoglobin as hemoglobin A1c in whole blood having extended shelf life at room temperature. The system comprising a blood dilution solution and a device adapted for receiving at least a portion of diluted blood solution, for contacting the blood solution with a dry reagent system, for detecting a change in the reagent system and for providing an indication of the analytical result to the user, and the extended shelf life and the elimination of a requirement for refrigeration for storage is achieved by having the blood dilution solution which comprises a first surfactant for hemolysis and a second surfactant for stability. The system of this invention is useful in other analysis kits and systems as well.
    Type: Grant
    Filed: January 16, 2004
    Date of Patent: December 19, 2006
    Assignee: Metrika, Inc.
    Inventors: Zongcen Charles Xie, Jeffrey A. Pierce, Carole R. Stivers
  • Patent number: 6509196
    Abstract: Methods for quantitatively measuring the amount of an analyte of interest in a fluid sample are disclosed. The methods involve providing a membrane having an application point, a detection zone, and a contact region, where the contact region is between the application point and the detection zone, and has test particles and internal control particles imbedded within it; contacting the application point with the fluid sample; maintaining the membrane under conditions sufficient to allow fluid to transport analyte by capillary action to the contact region, where the analyte binds to the test particles; further maintaining the membrane under conditions sufficient to allow fluid to transport analyte-bound test particles and internal control particles to the detection zone, where they interact with a detection reagent; and detecting the amount of test particles and the amount of internal control particles in the detection zone.
    Type: Grant
    Filed: January 4, 2000
    Date of Patent: January 21, 2003
    Assignee: Response Biomedical Corp.
    Inventors: Donald Elliott Brooks, Paul C. Harris, Andrew D. Olal, Zongcen Charles Xie, Brian G. Richards